Table 4.
Survivors (group 1) N = 133 |
Non-survivors (group 2) N = 39 |
P | |
---|---|---|---|
NT-proBNP [pg/mL] | 3068.0 ± 6172.2 | 8397.6 ± 11303.3 | < 0.001* |
GFR [mL/min/1.73 m2] | 46.4 ± 24.1 | 34.8 ± 22.0 | 0.008* |
Urea [mg/dL] | 31.1 ± 17.4 | 39.9 ± 23.0 | 0.011* |
Erythrocytes [T/L] | 4.5 ± 0.7 | 4.2 ± 0.7 | 0.039* |
Hemoglobin [g/dL] | 12.7 ± 1.8 | 12.0 ± 1.8 | 0.041* |
Hematocrit [%] | 39.2 ± 5.2 | 37.7 ± 5.3 | 0.116 |
Mean corpuscular volume [fL] | 88.1 ± 5.7 | 90.1 ± 7.5 | 0.077 |
Mean corpuscular hemoglobin [pg] | 28.6 ± 2.1 | 28.8 ± 2.7 | 0.670 |
Mean corpuscular hemoglobin concentration [g/dL] | 32.4 ± 1.2 | 31.9 ± 1.3 | 0.022* |
Data are presented as a mean ± standard deviation;
p < 0.05 (significant);
GFR — glomerular filtration rate; NT-proBNP — N-terminal-pro-B-type natriuretic peptide